Luteolin mitigates inflammatory organ injury by targeting XIAP to block PANoptosis and mitochondrial dysfunction

Key Points

• Luteolin effectively reduces inflammatory organ injury through the targeting of the XIAP pathway.
• A significant decrease in injury markers was observed with luteolin treatment, suggesting its protective role.
• The approach involves assessing the effects of luteolin on mitochondrial dysfunction and PANoptosis mechanisms.
• This study highlights the potential of luteolin as a therapeutic agent against organ injury, warranting further investigation.